Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy

scientific article published on 10 September 2015

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.5581
P932PMC publication ID4741816
P698PubMed publication ID26376679
P5875ResearchGate publication ID282042367

P2093author name stringChul Seung Kay
Hong Seok Jang
Seok Hyun Son
Jin Ho Song
P2860cites workHepatic radiation toxicity: avoidance and ameliorationQ27023687
Radiation therapy for hepatocellular carcinomaQ28248864
A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancerQ30442815
Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinomaQ33327962
Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinomaQ33593108
Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinomaQ33894890
Helical tomotherapy for single and multiple liver tumoursQ33975859
Global cancer statistics in the year 2000.Q34571897
Radiation-associated liver injury.Q35297759
Radiotherapy for unresectable hepatic malignanciesQ36267549
Partial volume tolerance of the liver to radiation.Q36267553
Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patientsQ36517404
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinomaQ36555907
Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosisQ36604392
Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinomaQ36811589
Radiation dose-volume effects in the lung.Q37695563
Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary systemQ43489446
Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy.Q43780887
Analysis of radiation-induced liver disease using the Lyman NTCP model.Q44048914
Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver diseaseQ44544539
Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child–Pugh Grade A cirrhosisQ45867321
Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.Q48801319
A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical noteQ49111475
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.Q51945500
Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity.Q53118337
Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.Q53528172
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular CarcinomaQ59678030
Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected casesQ81308087
Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation studyQ84114286
P433issue32
P407language of work or nameEnglishQ1860
P921main subjecthelical tomotherapyQ108575067
P304page(s)33952-33960
P577publication date2015-09-10
P1433published inOncotargetQ1573155
P1476titleReducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
P478volume6

Reverse relations

cites work (P2860)
Q36992992Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
Q41709047Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
Q26738533Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
Q37055687Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy

Search more.